Debridat Side Effects

Common Debridat Side Effects

The most commonly reported Debridat side effects (click to view or check a box to report):

Abdominal Pain (2)
Transaminases Increased (2)
Gamma-glutamyltransferase Increased (2)
Prothrombin Time Shortened (2)
Blood Bilirubin Increased (2)
Blood Alkaline Phosphatase Increased (2)
Surgery (1)
Vomiting (1)
Toxic Skin Eruption (1)
Palpitations (1)
Hyponatraemia (1)
Rash Morbilliform (1)
Skin Exfoliation (1)
Blood Pressure Increased (1)
Creatinine Renal Clearance Decreased (1)
Diarrhoea (1)
Cardiac Disorder (1)
Blood Pressure Decreased (1)
Dry Mouth (1)
Headache (1)

➢ More

If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Debridat Side Effects Reported to FDA

The following Debridat reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

The appearance of Debridat on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
This is a report of a 88-year-old male patient (weight: NA) from PE, suffering from the following symptoms/conditions: NA, who was treated with Debridat (dosage: NA, start time: NS), combined with:
  • Norvastor
and developed a serious reaction and side effect(s). The consumer presented with:
  • Surgery
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Debridat treatment in male patients, resulting in surgery side effect.

Rash Morbilliform
This report suggests a potential Debridat Rash Morbilliform side effect(s) that can have serious consequences. A 58-year-old female patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: NA and used Debridat (dosage: 1 Df, 4x/day) starting Jun 30, 2012. Soon after starting Debridat the patient began experiencing various side effects, including:
  • Rash Morbilliform
Drugs used concurrently:
  • Furosemide (Unk)
  • Rocephine (1 G, 1x/day)
  • Flagyl (1 Df, 3x/day)
  • Zophren (1 Df, As Needed)
  • Calciparin (1 Df, 2x/day)
  • Acupan (Unk)
  • Aranesp
  • Paracetamol (1 G, 4x/day)
The patient was hospitalized. Although Debridat demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as rash morbilliform, may still occur.

Prothrombin Time Shortened, Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased, Transaminases Increased, Blood Bilirubin Increased
This Prothrombin Time Shortened, Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased, Transaminases Increased, Blood Bilirubin Increased problem was reported by a health professional from FRANCE. A 48-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Jan 22, 2012 this consumer started treatment with Debridat (dosage: 100 Mg, 3x/day). The following drugs were being taken at the same time:
  • Levothyroxine Sodium
  • Ibuprofen (400 Mg, 3x/day)
When commencing Debridat, the patient experienced the following unwanted symptoms/side effects:
  • Prothrombin Time Shortened
  • Blood Alkaline Phosphatase Increased
  • Gamma-glutamyltransferase Increased
  • Transaminases Increased
  • Blood Bilirubin Increased
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as prothrombin time shortened, may become evident only after a product is in use by the general population.

Blood Alkaline Phosphatase Increased, Transaminases Increased, Prothrombin Time Shortened, Blood Bilirubin Increased, Gamma-glutamyltransferase Increased
This is a report of a 48-year-old male patient (weight: NA) from FRANCE. The patient developed the following symptoms/conditions: NA and was treated with Debridat (dosage: 100 Mg, 3x/day) starting Jan 22, 2012. Concurrently used drugs:
  • Ibuprofen (400 Mg, 3x/day)
  • Levothyroxine Sodium
Soon after that, the consumer experienced the following side effects:
  • Blood Alkaline Phosphatase Increased
  • Transaminases Increased
  • Prothrombin Time Shortened
  • Blood Bilirubin Increased
  • Gamma-glutamyltransferase Increased
The patient was hospitalized. This opens a possibility that Debridat treatment could cause the above reactions, including blood alkaline phosphatase increased, and some male subjects may be more susceptible.

Intestinal Obstruction, Abdominal Pain, Nausea
A male patient (weight: NA) from FRANCE with the following symptoms/conditions: NA started Debridat treatment (dosage: 100mg Three Times Per Day) on Feb 06, 2012. Soon after starting Debridat treatment, the subject experienced various side effects, including:
  • Intestinal Obstruction
  • Abdominal Pain
  • Nausea
Concurrently used drugs:
  • Spasfon (30mg Twice Per Day)
  • Doxorubicin Hcl (44mg Per Day)
  • Isentress (400mg Twice Per Day)
  • Vinblastine Sulfate (10.5mg Per Day)
  • Acetaminophen And Tramadol Hcl (1unit Twice Per Day)
  • Norvir (100mg Twice Per Day)
  • Creon (25000iu Four Times Per Day)
  • Motilium
The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Debridat.

Toxic Skin Eruption, Skin Exfoliation
A 58-year-old female patient from FRANCE (weight: NA) experienced symptoms, such as: NA and was treated with Debridat(dosage: 600 Mg, 1x/day). The treatment was initiated on Oct 31, 2001. After that a consumer reported the following side effect(s):
  • Toxic Skin Eruption
  • Skin Exfoliation
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Debridat efficacy:
  • Medrol (16 Mg, 3x/day)
  • Fluconazole (50 Mg, 2x/day)
  • Omeprazole (20 Mg, 1x/day)
  • Motilium-m
  • Mineral Tab
  • Ferrous Gluconate
  • Lasix (20 Mg, 1x/day)
  • Taxol (140 Mg, 1x/day)
The patient was hospitalized.

Cardiac Disorder, Blood Pressure Increased, Headache, Malaise, Palpitations, Blood Pressure Decreased
In this report, Debridat was administered for the following condition: NA.A 84-year-old female consumer from MEXICO (weight: NA) started Debridat treatment (dosage: Unk) on Jun 01, 2009.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Cardiac Disorder
  • Blood Pressure Increased
  • Headache
  • Malaise
  • Palpitations
  • Blood Pressure Decreased
A possible interaction with other drugs could have contributed to this reaction:
  • Diovan Hct (1 Tablet (160/12.5mg) Daily)
  • Clonazepam
  • Diovan Hct (1 Tablet (80/12.5 Mg) Daily)
Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Debridat treatment could be related to the listed above side effect(s).

Dry Mouth, Creatinine Renal Clearance Decreased, Hypotension, Hyponatraemia
This is a report of the following Debridat side effect(s):
  • Dry Mouth
  • Creatinine Renal Clearance Decreased
  • Hypotension
  • Hyponatraemia
A female patient from FRANCE (weight: NA) presented with the following condition: NA and received a treatment with Debridat (dosage: NA) starting: NS.The following concurrently used drugs could have generated interactions:
  • Nexium (20 Mg, Each Evening)
  • Aldactone (75 Mg, Each Morning)
  • Aprovel /fra/ (75 Mg, Each Morning)
  • Anafranil (25 Mg, Each Evening)
  • Ciflox (Unk, 2/d)
  • Lyrica (50 Mg, 2/d)
  • Alprazolam (0.25 Mg, Daily (1/d))
  • Transipeg /fra/
The patient was hospitalized.This report suggests that a Debridat treatment could be associated with the listed above side effect(s).

Diarrhoea, Abdominal Pain, Weight Decreased, Vomiting
This Debridat report was submitted by a 61-year-old male consumer from FRANCE (weight: NA). The patient was diagnosed with: NA and Debridat was administered (dosage: NA) starting: Jan 17, 2007. The consumer developed a set of symptoms:
  • Diarrhoea
  • Abdominal Pain
  • Weight Decreased
  • Vomiting
Other drugs used simultaneously:
  • Smecta
  • Revlimid
  • Tiorfan
The patient was hospitalized.Those unexpected symptoms could be linked to a Debridat treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Discuss Debridat Side Effects

    Did You Have a Debridat Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor

    How Effective is Debridat for You?

    Exceeded Expectations
    Somewhat Effective
    Not Effective

    Debridat Safety Alerts, Active Ingredients, Usage Information

    More About Debridat

    Side Effects reported to FDA: 9

    Debridat safety alerts: No

    Reported hospitalizations: 7

    Latest Debridat clinical trials

    Debridat Reviews

    No reviews, be a first to report a side effect via side effect reporting form